The method uses a NeuN-specific antibody to identify nuclei or cells carrying the marker, then directs the unlabeled fraction into a separate collection. This exclusion-based strategy enriches material lacking detectable NeuN rather than directly labeling every non-neuronal cell. The resulting population therefore reflects the sorting criteria and the biological composition of the starting brain tissue.
NeuN is commonly associated with mature neurons, so its absence provides a practical basis for separating material that does not display that neuronal marker. However, the NeuN-negative fraction should be interpreted as marker-negative rather than automatically equivalent to one cell type. Its contents can include glial and other supporting populations, with composition influenced by tissue source and experimental design.
NeuN-negative sorting emphasizes recovery of material excluded by the NeuN label, while the corresponding NeuN-positive material is identified through antibody-associated fluorescence. This distinction is useful when the experimental question concerns non-neuronal or supporting populations rather than mature neuron-associated material. Comparing the fractions can also improve cellular resolution by separating marker-defined groups for subsequent analyses.
Enrichment depends primarily on the tissue examined and the design of the experiment. Because NeuN-negative material may contain multiple non-neuronal and supporting populations, the sorted fraction is not inherently uniform. Researchers must therefore relate its composition to the sampled brain region and sorting strategy before interpreting molecular or functional differences as properties of a single cell class.
A typical workflow begins by dissociating brain tissue into cells or nuclei suitable for analysis. The preparation is then exposed to a NeuN-specific antibody so NeuN-associated material can be identified. Fluorescence-activated or a related sorting method separates the labeled fraction from the unlabeled fraction, which is collected as the NeuN-negative population for downstream study.
The enriched fraction can support gene-expression, epigenetic, and functional analyses. Separating populations before these measurements reduces the chance that signals from different cellular groups will be averaged together in the starting tissue. This higher resolution can help investigators examine molecular or functional characteristics associated with NeuN-negative brain populations in a more focused way.
Brain tissue contains diverse cellular populations whose combined measurements can obscure cell-specific patterns. Enriching the NeuN-negative fraction helps researchers examine non-neuronal and other supporting populations separately from NeuN-associated material. In studies of brain organization and disease, this separation can improve resolution and make population-specific gene-expression, epigenetic, or functional findings easier to evaluate.